Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Treasury Shares: 2016-2024

Historic Treasury Shares for Wave Life Sciences (WVE) over the last 9 years, with Dec 2024 value amounting to $832,043.

  • Wave Life Sciences' Treasury Shares rose 116.91% to $1.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year increase of 116.91%. This contributed to the annual value of $832,043 for FY2024, which is 30.50% up from last year.
  • According to the latest figures from FY2024, Wave Life Sciences' Treasury Shares is $832,043, which was up 30.50% from $637,557 recorded in FY2023.
  • In the past 5 years, Wave Life Sciences' Treasury Shares registered a high of $1.9 million during FY2021, and its lowest value of $637,557 during FY2023.
  • In the last 3 years, Wave Life Sciences' Treasury Shares had a median value of $832,043 in 2024 and averaged $801,314.
  • Its Treasury Shares has fluctuated over the past 5 years, first surged by 58.90% in 2021, then plummeted by 50.18% in 2022.
  • Wave Life Sciences' Treasury Shares (Yearly) stood at $1.2 million in 2020, then spiked by 58.90% to $1.9 million in 2021, then plummeted by 50.18% to $934,342 in 2022, then plummeted by 31.76% to $637,557 in 2023, then soared by 30.50% to $832,043 in 2024.